The DOI matches its Crossref record; 8 of the 8 references it cites were found in a registry or an index.
Liver is the major source of elevated serum lipocalin‐2 levels after bacterial infection or partial hepatectomy: A critical role for IL‐6/STAT3
Open accessAbstract
Lipocalin‐2 (LCN2) was originally isolated from human neutrophils and termed neutrophil gelatinase‐associated lipocalin (NGAL). However, the functions of LCN2 and the cell types that are primarily responsible for LCN2 production remain unclear. To address these issues, hepatocyte‐specific Lcn2 knockout (Lcn2Hep–/–) mice were generated and subjected to bacterial infection (with Klesbsiella pneumoniae or Escherichia coli)or partial hepatectomy (PHx). Studies of Lcn2Hep–/–mice revealed that hepatocytes contributed to 25% of the low basal serum level of LCN2 protein (∼62 ng/mL) but were responsible for more than 90% of the highly elevated serum LCN2 protein level (∼6,000 ng/mL) postinfection and more than 60% post‐PHx (∼700 ng/mL). Interestingly, both Lcn2Hep–/–and global Lcn2 knockout (Lcn2–/–) mice demonstrated comparable increases in susceptibility to infection with K. pneumoniae or E. coli. These mice also had increased enteric bacterial translocation from the gut to the mesenteric lymph nodes and exhibited reduced liver regeneration after PHx. Treatment with interleukin (IL)‐6 stimulated hepatocytes to produce LCN2 in vitro and in vivo. Hepatocyte‐specific ablation of the IL‐6 receptor or Stat3, a major downstream effector of IL‐6, markedly abrogated LCN2 elevation in vivo. Furthermore, chromatin immunoprecipitation (ChIP) assay revealed that STAT3 was recruited to the promoter region of the Lcn2 gene upon STAT3 activation by IL‐6.Conclusion: Hepatocytes are the major cell type responsible for LCN2 production after bacterial infection or PHx, and this response is dependent on IL‐6 activation of the STAT3 signaling pathway. Thus, hepatocyte‐derived LCN2 plays an important role in inhibiting bacterial infection and promoting liver regeneration. (H epatology 2015;61:692‐702)
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Goetz, D. H., Holmes, M. A., Borregaard, N., Bluhm, M. E., Raymond, K. N., & Strong, R. K. (2002) · Molecular Cell · doi:10.1016/s1097-2765(02)00708-6 · Cited by 1,355
Self-citationLiver: An organ with predominant innate immunity
Gao, B., Jeong, W.-I., & Tian, Z. (2008) · Hepatology · doi:10.1002/hep.22034 · Cited by 952
Self-citationRaffatellu, M., George, M. D., Akiyama, Y., Hornsby, M. J., Nuccio, S.-P., Paixao, T. A., Butler, B. P., Chu, H., Santos, R. L., Berger, T., et al. (2009) · Cell Host & Microbe · doi:10.1016/j.chom.2009.03.011 · Cited by 525 · cited 1×
“Up-regulation of LCN2 protein and mRNA postbacterial infection has been reported in several organs other than the liver, including the lung and intestine.(3,28) Up-regulation of LCN2 protein in these organs may contribute to only a small proportion of the observed elevation in serum LCN2 protein, although together wit…”
BackgroundSelf-citationChakraborty, S., Kaur, S., Guha, S., & Batra, S. K. (2012) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2012.03.008 · Cited by 503 · cited 4×
“The antibacterial effects of LCN2 have been well documented in various infection models.(5,12-15) Here, we demonstrated that Lcn2 mice and Lcn2 mice showed comparable mortality after K.”
BackgroundInfluentialBerger, T., Togawa, A., Duncan, G. S., Elia, A. J., You-Ten, A., Wakeham, A., Fong, H. E. H., Cheung, C. C., & Mak, T. W. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0510847103 · Cited by 460
Self-citationLipocalin 2 deactivates macrophages and worsens pneumococcal pneumonia outcomes
Warszawska, J. M., Gawish, R., Sharif, O., Sigel, S., Doninger, B., Lakovits, K., Mesteri, I., Nairz, M., Boon, L., Spiel, A., et al. (2013) · Journal of Clinical Investigation · doi:10.1172/jci67911 · Cited by 148
Hepatocyte-specific mutation of both NF-κB RelA and STAT3 abrogates the acute phase response in mice
Quinton, L. J., Blahna, M. T., Jones, M. R., Allen, E., Ferrari, J. D., Hilliard, K. L., Zhang, X., Sabharwal, V., Algül, H., Akira, S., et al. (2012) · Journal of Clinical Investigation · doi:10.1172/jci59408 · Cited by 84 · cited 1×
“pneumoniae infection-induced elevation of hepatic Lcn2 mRNA and serum LCN2 protein, although it is not clear whether the induction of LCN2 required activation of both Stat3 and Nf-κb.(29) In the current Page 15 of 38”
BackgroundLipocalin 2 is protective against E. coli pneumonia
Wu, H., Santoni-Rugiu, E., Ralfkiaer, E., Porse, B. T., Moser, C., Høiby, N., Borregaard, N., & Cowland, J. B. (2010) · Respiratory Research · doi:10.1186/1465-9921-11-96 · Cited by 82
Self-citation
Cited by
Alcoholic liver disease: mechanisms of injury and targeted treatment
Louvet, A., & Mathurin, P. (2015) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/nrgastro.2015.35 · Cited by 855
Hepatocytes: a key cell type for innate immunity
Zhou, Z., Xu, M.-J., & Gao, B. (2016) · Cellular & Molecular Immunology · doi:10.1038/cmi.2015.97 · Cited by 472
Self-citationLipocalin-2: A Master Mediator of Intestinal and Metabolic Inflammation
Moschen, A. R., Adolph, T. E., Gerner, R. R., Wieser, V., & Tilg, H. (2017) · Trends in Endocrinology & Metabolism · doi:10.1016/j.tem.2017.01.003 · Cited by 359
Lipocalin-2: Structure, function, distribution and role in metabolic disorders
Jaberi, S. A., Cohen, A., D’Souza, C., Abdulrazzaq, Y. M., Ojha, S., Bastaki, S., & Adeghate, E. A. (2021) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2021.112002 · Cited by 345
Singh, V., Yeoh, B. S., Chassaing, B., Zhang, B., Saha, P., Xiao, X., Awasthi, D., Shashidharamurthy, R., Dikshit, M., Gewirtz, A., et al. (2016) · Cellular and Molecular Gastroenterology and Hepatology · doi:10.1016/j.jcmgh.2016.03.007 · Cited by 117
CREBZF as a Key Regulator of STAT3 Pathway in the Control of Liver Regeneration in Mice
Hu, Z., Han, Y., Liu, Y., Zhao, Z., Ma, F., Cui, A., Zhang, F., Liu, Z., Xue, Y., Bai, J., et al. (2020) · Hepatology · doi:10.1002/hep.30919 · Cited by 65
Self-citationStress increases hepatic release of lipocalin 2 which contributes to anxiety-like behavior in mice
Yan, L., Yang, F., Wang, Y., Shi, L., Wang, M., Yang, D., Wang, W., Jia, Y., So, K.-F., & Zhang, L. (2024) · Nature Communications · doi:10.1038/s41467-024-47266-9 · Cited by 63
Functions and regulation of lipocalin-2 in gut-origin sepsis: a narrative review
Lu, F., Inoue, K., Kato, J., Minamishima, S., & Morisaki, H. (2019) · Critical Care · doi:10.1186/s13054-019-2550-2 · Cited by 60
Inflammatory response and oxidative stress during liver resection
Schwarz, C., Fitschek, F., Bar-Or, D., Klaus, D. A., Tudor, B., Fleischmann, E., Roth, G., Tamandl, D., Wekerle, T., Gnant, M., et al. (2017) · PLOS ONE · doi:10.1371/journal.pone.0185685 · Cited by 47
Hepatic chemerin mRNA expression is reduced in human nonalcoholic steatohepatitis
Pohl, R., Haberl, E. M., Rein‐Fischboeck, L., Zimny, S., Neumann, M., Aslanidis, C., Schacherer, D., Krautbauer, S., Eisinger, K., Weiss, T. S., et al. (2017) · European Journal of Clinical Investigation · doi:10.1111/eci.12695 · Cited by 45
Cramer, E. P., Dahl, S. L., Rozell, B., Knudsen, K. J., Thomsen, K., Moser, C., Cowland, J. B., & Borregaard, N. (2017) · Blood · doi:10.1182/blood-2016-11-753434 · Cited by 22
Self-citationLipocalin-2 and intestinal diseases
Zhang, Z.-X., Peng, J., & Ding, W.-W. (2024) · World Journal of Gastroenterology · doi:10.3748/wjg.v30.i46.4864 · Cited by 19
Metadata
- Authors
- Xu, M., Feng, D., Wu, H., Wang, H., Chan, Y., Kolls, J., Borregaard, N., Porse, B., Berger, T., Mak, T. W., Cowland, J. B., Kong, X., & Gao, B.
- Venue
- Hepatology
- Published
- 2015-01-20
- Volume
- 61
- Issue
- 2
- Pages
- 692-702
- ISSN
- 0270-9139 (ISSN-L)
- 1527-3350
- OpenAlex
- W1989787732
- Cited by
- 178
- References
- 8
- FWCI
- 7.47
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.